Document:

EX-4.5

 Exhibit 4.5 

THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE
THEREOF. THIS SECURITY MAY NOT BE TRANSFERRED TO, OR REGISTERED OR EXCHANGED FOR SECURITIES REGISTERED IN THE NAME OF, ANY PERSON OTHER THAN THE DEPOSITORY OR A NOMINEE THEREOF AND NO SUCH TRANSFER MAY BE REGISTERED, EXCEPT IN THE LIMITED
CIRCUMSTANCES DESCRIBED IN THE INDENTURE. EVERY SECURITY AUTHENTICATED AND DELIVERED UPON REGISTRATION OF TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW
YORK CORPORATION (“DTC”), TO THE COMPANY (AS DEFINED BELOW) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY
AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON
IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 CAMDEN PROPERTY TRUST 

4.100% NOTE DUE 2028 
  

			
	REGISTERED	  	PRINCIPAL AMOUNT
	No.: R-1	  	$400,000,000

 CUSIP No.:  133131 AW2 

ISIN No.:  US133131AW29 
 CAMDEN
PROPERTY TRUST, a real estate investment trust organized and existing under the laws of the State of Texas (hereinafter called the “Company,” which term includes any successor corporation under the Indenture hereinafter referred to), for
value received, hereby promises to pay to CEDE & Co., or registered assigns, upon presentation, the principal sum of Four Hundred Million Dollars ($400,000,000) on October 15, 2028 at the office or agency of the Company referred to
below, and to pay interest thereon from October 4, 2018, or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on April 15 and October 15 in each year (each, an
“Interest Payment Date”), commencing April 15, 2019 at the rate of 4.100% per annum, until the entire principal hereof is paid or duly provided for. The interest so payable, and punctually paid or duly provided for on any Interest
Payment Date will, as provided for in the Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest which shall be
April 1 or October 1 (whether or not a Business Day), as the case may be, immediately preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holder on
such Regular Record Date, and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed
by the Trustee, notice whereof shall be given to Holders of Securities of this series not more than 15 days and not less than 10 days prior to such Special Record Date, or may be paid at any time in any other lawful manner not inconsistent with the
requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in the Indenture. 

Payment of the principal of, or Make-Whole Amount, if any, and interest on, the Securities will be made to The Depository Trust Company or its
nominee in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by
(i) check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (ii) by wire transfer of funds to an account of the Person entitled thereto maintained within the United States. 

 Securities of this series may be redeemed at any time at the option of the Company, in whole
or in part, upon notice of not more than 60 nor less than 15 days prior to the Redemption Date, at a redemption price equal to the sum of (i) an amount equal to 100% of the principal amount of the Securities being redeemed and (ii) the
Make-Whole Amount, if any, with respect to such Securities, together with accrued and unpaid interest up to but not including the Redemption Date; provided, however, that if the Securities are redeemed on or after the Par Call Date, the redemption
price will equal 100% of the principal amount of the Securities (or portion of the Securities) being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date. 

REFERENCE IS HEREBY MADE TO THE FURTHER PROVISIONS OF THIS SECURITY SET FORTH ON THE REVERSE HEREOF, WHICH FURTHER PROVISIONS SHALL FOR ALL
PURPOSES HAVE THE SAME EFFECT AS IF SET FORTH IN THIS PLACE. 
 Unless the Certificate of Authentication hereon has been executed by or on
behalf of the Trustee by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

							
	Dated: October 4, 2018	 		 	CAMDEN PROPERTY TRUST
				
		 		 	By:	 	 
		 		 		 	Alexander J. Jessett
		 		 		 	Executive Vice President – Finance, Chief Financial Officer and Treasurer

  

			
	Attest:
		
	By:	 	 
		 	Joshua L. Lebar
		 	Senior Vice President – General Counsel and Secretary

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION: 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

							
	 U.S. Bank National Association, as successor to SunTrust Bank,

as Trustee
	 		 	
				
	By:	 	 	 		 	Dated: October 4, 2018
		 	Authorized Officer	 		 	

  
 2 

 Reverse of Note 

CAMDEN PROPERTY TRUST 
 4.100%
NOTE DUE 2028 
 This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”),
issued and to be issued in one or more series under an Indenture, dated as of February 11, 2003, as amended by the First Supplemental Indenture, dated as of May 4, 2007, the Second Supplemental Indenture, dated as of June 3, 2011 and
the Third Supplemental Indenture, dated as of October 4, 2018 (collectively, herein called the “Indenture”), between the Company and U.S. Bank National Association, a banking corporation organized and existing under the laws of the
United States of America, as successor to SunTrust Bank, as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture with respect to the series of which this Security is a part), to which
Indenture and all board resolutions and indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the
Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the first page hereof. 

“Make-Whole Amount” means, in connection with any optional redemption or accelerated payment of any Security, the excess, if any, of
(i) the aggregate present value as of the date of such redemption or accelerated payment of each dollar of principal being redeemed or paid and the amount of interest (exclusive of interest accrued to the date of redemption or accelerated
payment) that would have been payable in respect of such dollar if such redemption or accelerated payment had not been made, assuming that the Securities matured on, and that accrued and unpaid interest on the Securities was payable through, the Par
Call Date (as defined below), determined by discounting, on a semi-annual basis, such principal and interest at the Reinvestment Rate (as defined below) determined on the third Business Day preceding the date such notice of redemption is given or
declaration of acceleration is made from the respective dates on which such principal and interest would have been payable if such redemption or accelerated payment had not been made, over (ii) the aggregate principal amount of the Securities
being redeemed or paid. 
 “Par Call Date” means July 15, 2028, the date that is three months prior to the maturity date of
the Securities. 
 “Reinvestment Rate” means 0.200% (twenty one-hundredths of one percent)
plus the arithmetic mean of the yields displayed for each day in the preceding calendar week published in the most recent Statistical Release (as defined below) under the caption “Treasury constant maturities” for the maturity (rounded to
the nearest month) corresponding to the then remaining maturity of such Securities being redeemed or paid, assuming that such Securities matured on the Par Call Date. If no maturity exactly corresponds to such maturity date, the Reinvestment Rate
will be obtained by linear interpolation (calculated to the nearest one-twelfth of a year) from the yields for the two published maturities most closely corresponding to such maturity date. 

“Statistical Release” means the statistical release designated “H.15” or any successor publication that is published daily
by the Federal Reserve System and that establishes yields on actively traded United States Treasury securities adjusted to constant maturities or, if such statistical release (or a successor publication) is not published at the time of any
determination under the Indenture, then such other reasonably comparable index which shall be designated by the Company. 
 Notwithstanding
Section 4 of the First Supplemental Indenture, the covenants set forth in Section 10.12 of the Indenture shall be fully applicable to this Security. 

The Indenture contains provisions for defeasance at any time of (a) the entire indebtedness of the Company on this Security and
(b) certain restrictive covenants and the related defaults and Events of Default applicable to the Company, in each case, upon compliance by the Company with certain conditions set forth in the Indenture, which provisions apply to this
Security. 
 If any Event of Default with respect to Securities of this series shall occur and be continuing, the principal of, and the
Make-Whole Amount, if any, on, the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

  
 3 

 As provided in and subject to the provisions of the Indenture, the Holder of this Security
shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a
continuing Event of Default with respect to the Securities of this series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to institute
proceedings in respect of such Event of Default as Trustee, offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a
direction inconsistent with such request, and the Trustee shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the
Holder of this Security for the enforcement of any payment of principal hereof (and premium or Make-Whole Amount, if any) or any interest on and any Additional Amounts in respect thereof on or after the respective due dates expressed herein. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in principal amount of the
Securities of each series at the time Outstanding affected thereby. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the
Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Security. 
 No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter
or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, Make-Whole Amount, if any, on, and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the
Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any Place of Payment where the principal of, Make-Whole Amount, if any, on, and interest on this Security are payable, duly
endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities
of this series, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Securities of this series are issuable only in registered form without coupons in denominations of $2,000 and integral multiples of
$1,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series of a different authorized denomination, as
requested by the Holder surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to
due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not
this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
 No
recourse under or upon any obligation, covenant or agreement contained in the Indenture or in this Security, or because of any indebtedness evidenced thereby, shall be had against any promoter, as such or, against any past, present or future
shareholder, officer, trust manager or director, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment
or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of this Security by the Holder thereof and as part of the consideration for the issue of the Securities of this series.

  
 4 

 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. 
 THE INDENTURE AND THE SECURITIES, INCLUDING THIS SECURITY, SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK. 
 Pursuant to a recommendation promulgated by the Committee on Uniform Security
Identification Procedures, the Company has caused “CUSIP” numbers to be printed on the Securities of this series as convenience to the Holders of such Securities. No representation is made as to the correctness or accuracy of such CUSIP
number, or the ISIN number, printed on the Securities of this series, and reliance may be placed only on the other identification numbers printed hereon. 

[REMAINDER OF PAGE INTENTIONALLY BLANK] 

  
 5 

 ABBREVIATIONS 

The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out
in full according to applicable laws or regulations: 
  

							
	TEN COMM    	 	—	  	as tenants in common	  	UNIF GIFT/TRANSFER MIN ACT —
	TEN ENT	 	—	  	as tenants by the entireties	  	                    Custodian
                   
	JT TEN	 	—	  	as joint tenants with rights of survivorship and not at tenants in common	  	
    (Cust)                     
     (Minor)
 Under Uniform Gifts/Transfer to Minors Act

                  

	 	 	 	  	 	  	(State)

 Additional abbreviations may also be used though not in the above list. 

Social Security or taxpayer I.D. or other identifying number of assignee: 
  

 
 FOR VALUE RECEIVED, the
undersigned hereby sells, assigns and transfers unto 
  
  

(name and address of assignee) 
 the within Note
and all rights thereunder, hereby irrevocably constituting and appointing
                                         
   , attorney to transfer said Note on the books kept for registration thereof, with full power of substitution in the premises. 
 Dated:

  
 6Exhibit 4.3

MorphoSys US Inc. n 100 Overlook Center Suite #2109 n Princeton, NJ  08540

September 6, 2018

James Hussey

15 Mulberry Drive

Hawthorn Woods, IL  60047

Re: Offer of Employment

Dear James,

On behalf of MorphoSys US Inc. (the “Company”), we are pleased to offer you a part-time position as Special Advisor to the Chairman. Your employment is subject to the terms and conditions set forth in this letter and to all of the Company’s applicable employment and other policies in effect from time to time, including the Company’s employee handbook.

	1.	
Start Date.  Your employment will start on September 10, 2018 or on such other date as you and the Company mutually agree (“Start Date”).

	2.	
Position.  In your position as Special Advisor to the Chairman, you will report to the Chairman of MorphoSys US Inc. (“Supervisor”). During your employment, you will be expected to comply with all instructions and directions given to you by the Supervisor and his designees, as appointed by the Supervisor in writing from time to time, all applicable laws and regulations, and the Company’s internal guidelines and policies in effect from time to time.  Your employment is part-time (70%), and unless otherwise instructed by the Supervisor, you may determine your work time at your discretion.  During your work time, you agree to devote your best efforts to the performance of your duties in furtherance of the Company’s business.  A copy of your job description is attached as Exhibit A, as the same may be changed by the Company from time to time.

	3.	
Compensation. In consideration of your services, your compensation will be as follows:

		a.	
Base Salary.  Your annual base salary will be $370,000.00 (“Base Salary”), payable in 24 equal semi-monthly installments in accordance with the Company’s standard payroll schedule.

		b.	
Annual Bonus.  You will be eligible for a target annual bonus of 50% of your Base Salary for 100% achievement of your agreed upon targets (“Annual Bonus”).   If you do not reach 100% of your targets, you will be eligible for a prorated amount of the Annual Bonus.  Your targets will be agreed upon by you and the Company for each business year by January 31 of the applicable business year.  However, for the 2018 business year, your targets will be established within four (4) weeks of your Start Date.  If you are eligible for an Annual Bonus as to any business year during your employment, such Annual Bonus shall be payable on or prior to March 15 of the following business year. For partial years of employment, you will be eligible for a prorated bonus amount.

		c.	
Initial Equity Grant. On or as soon as practicable following your Start Date, but no later than thirty (30) business days thereafter, including – if applicable – following

	
- 1 -

			
registration under the Securities Act of 1933 (the “Grant Date”), MorphoSys AG (the “Parent Company”) shall grant you equity in the form of Parent Company (“MOR”) ordinary shares, stemming from treasury shares held by Parent Company (the “Shares”), in accordance with the terms and conditions set forth herein.  Parent Company shall make such equity grant to you with an overall value of $370,000.00 (the “Initial Equity Grant”), with the number of Shares to be granted determined by dividing $370,000.00 by the average closing price of MOR Shares as quoted in Xetra on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, FWB) on the thirty (30) trading days prior to the Start Date and rounding down to the nearest whole Share.  The Initial Equity Grant will be subject to a monthly vesting schedule, with 100% of the Shares fully vesting on the first anniversary of the Grant Date, provided that you are still employed with the Company on the respective vesting dates.  The Initial Equity Grant and each vesting of such grant shall be subject in all respects to applicable U.S. securities laws. For purposes of clarity, you shall have no claim or right to shares that have not vested as of the date of your termination from employment.

		d.	
Long-Term Incentive Program.  You will be eligible to participate in a long-term incentive compensation (“LTIC”) program with an annual grant value of $210,000.00 (the “LTIC Award”).   The Company, in its sole and unilateral discretion, may elect to pay greater LTIC in any year, based on the Company’s annual, financial and operating performance and any other factors that the Company may deem appropriate.  The Company is currently working to establish the LTIC program. Payment, vesting scheduling, and all other terms of such incentive award shall be subject to the applicable LTIC program as in effect from time to time.

		e.	
Clawback Provisions.  Any amounts payable under this offer letter are subject to any policy (whether in existence as of the date of this letter or later adopted) established by the Company providing for clawback or recovery of amounts that were paid to you. The Company will make any determination for clawback or recovery in its sole discretion and in accordance with any applicable law or regulation.

		f.	
Withholdings.  All compensation you receive from the Company will be less applicable taxes and payroll deductions and payable in accordance with the Company’s standard payroll practices as in effect from time to time.  The compensation is subject to any applicable law, rule and regulation.

	4.	
Benefits.  At this time, the Company does not participate in any benefit plans but fully intends to establish at least industry-standard benefit programs including medical insurance, dental and vision plans, 401(k) retirement, short-term and long-term disability, and group life insurance. You will be eligible to participate in any benefit plans and programs that the Company may make available to similarly situated employees on the terms and conditions offered to such employees.  Eligibility and participation in any such plans will be governed by the applicable documents governing each such plan.

	5.	
Paid Time Off. In addition to Company recognized public holidays, you will be entitled to fourteen (14) days of paid time off per year pursuant to the Company’s policies as may be in effect from time to time. These days will be prorated in any partial year of employment.

	
- 2 -

	6.	
Work Authorization.  Federal law requires the Company to document an employee’s authorization to work in the United States. To comply, the Company must have a completed I-9 Form for you within (3) three business days of your start date. You agree to provide the Company with the necessary documents required by the I-9 Form to confirm that you are authorized to work in the United States. The form I-9 will be provided to you along with all other documents on the date of your hire.

	7.	
Restrictive Covenants.  By signing this letter, you represent and acknowledge that (i) you are not subject to any employment agreement or any other agreement that would preclude the Company from offering this position to you or from you accepting this position and joining our organization; and (ii) you will not be asked or required to disclose to us or utilize any confidential or proprietary information from your prior places of employment and you understand that you must not do so.

	8.	
Confidentiality.  As a condition to employment, on or prior to the commencement of your employment, you must sign a confidentiality, agreement, requiring you to maintain the confidentiality of the Company’s trade secret and confidential information and to adhere to certain other restrictive covenants and obligations concerning the Company’s proprietary information, including non-competition, non-solicitation of employees and non-solicitation of customers.  A copy of the Company’s Confidentiality, Inventions and Restrictive Covenants Agreement is attached as Exhibit B.  Please review and return a signed copy of the agreement along with a countersigned copy of this letter prior to the Start Date.

	9.	
Background Check. Because of the nature of our business, our offer of employment and any continued employment may be contingent upon the results of a background investigation, including your education, your previous employment, criminal record and other facts that we deem relevant in our sole discretion and as otherwise permitted by law.

	10.	
At-Will Employment.  Your employment with the Company is not for any specific period of time; instead, your employment is at all times “at-will.”  This means that you may terminate your employment with or without cause or prior notice at any time, and the Company has the same right. The at-will nature of your employment may only be changed by an express written agreement signed by an authorized officer of the Company.

	11.	
No Prior Agreement. These provisions expressly supersede any previous representations, oral or written, made to you by the Company or any of its representatives.

	12.	
Applicable Law.  Any legal issues concerning the terms and conditions of your employment will be governed by and construed in accordance with the domestic laws of the State of New Jersey, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New Jersey or any other jurisdiction) that would defer to, or cause the application of, the substantive laws of another jurisdiction.

You should review this letter and the terms and make sure that they are consistent with your expectations and understandings. If so, please sign this letter confirming your agreement to the terms. By countersigning a copy of this letter, you acknowledge that this letter and the Company’s written policies as may be in effect from time to time contain all terms of your employment and that nothing that may have been said during any conversations with Company representatives in any way supplements, alters, or modifies these terms.

	
- 3 -

Once, again, all of us at the Company are excited to have you join our team.

Sincerely,

MorphoSys US Inc.

	
/s/ Dr. Simon Moroney

	 
	 	 
	
Dr. Simon Moroney

	 
	
Chairman of the Board, MorphoSys US Inc.  

	 
	 	 
	
/s/ Jens Holstein

	 
	 	 
	
Jens Holstein

	 
	
Treasurer, MorphoSys US Inc.

	 

ACCEPTANCE OF OFFER:

I have read and understood and I accept all the terms of the offer of employment as set forth in the foregoing letter. I have not relied on any agreements or representations, express or implied, that are not set forth expressly in the foregoing letter, and this letter supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to the subject matter of this letter.

	 	
 

/s/ James Hussey  

	 
	
Name     

	
James Hussey

 

 

	 
	
Date

	
9/11/2018

	 

	
- 4 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]